Biotech stocks are driven by regulatory and clinical trial catalysts. Knowledge about the timing of FDA decisions and release of clinical trial results will help trade biotech stocks with some margin of safety around the catalyst events.
from RTT - Biotech https://ift.tt/2KpsuAm
via IFTTT
No comments:
Post a Comment